The process involves the use of synthetic molecules called antisense oligonucleotides (AONs). These AONs bind to specific sequences of RNA, masking the faulty exon so that it is skipped during mRNA splicing. As a result, the remaining exons are joined together, producing a shorter but functional protein.
